Pharmacist Advanced Training Menopause/Perimenopause On-Demand 8h

Pharmacists play a critical role in supporting women through the often-challenging transitions of perimenopause, menopause, and post-menopause. This course will equip you with the knowledge to understand hormonal changes, recommend evidence-based management strategies, and explore both pharmacological and self-care options, including the safe use of supplements and hormone replacement therapy (HRT). Take this opportunity to enhance your expertise and become a trusted resource for patients navigating these life stages—because better care starts with informed pharmacists.

Learning Objectives

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. Define perimenopause, menopause, and post-menopause.
2. Differentiate between perimenopause, menopause, and postmenopause.
3. Identify characteristic symptoms of each reproductive stage.
4. Explain hormone fluctuations during menopause.
5. Use the orchestra analogy to describe hormone changes.
6. List common symptoms of perimenopause and menopause.
7. Recommend evidence-based management strategies for menopause symptoms.
8. Analyze lifestyle changes for managing menopause symptoms.
9. Discuss non-pharmacological self-care for symptom relief.
10. Evaluate the efficacy of supplements for symptom management.
11. Assess the safety of supplements in menopause care.
12. Discuss the benefits of hormone replacement therapy (HRT).
13. Analyze risks associated with HRT.
14. Compare different HRT forms and their indications.
15. Recommend appropriate HRT based on patient needs.
16. Identify pharmacist strategies for menopause education.
17. Develop symptom management plans with patients.
18. Utilize practical counseling techniques for individualized care.
19. Provide support to patients during menopause transitions.
A20. Promote individualized care plans for menopause symptom management.

Faculty

Anna Garrett, PharmD, BCPS, AFMCP

CEO
Dr. Anna Garrett

Disclosures:

Anna Garrett has no relevant financial relationships with ineligible companies to disclose.

Course Details